Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2026-02-01 @ 3:51 PM
Study NCT ID:
NCT02643420
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2015-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SPI-GCF-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None